p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults

A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuromolecular medicine 2003-01, Vol.3 (3), p.159-172
Hauptverfasser: Gilman, Charles P, Chan, Sic L, Guo, Zhihong, Zhu, Xiaoxiang, Greig, Nigel, Mattson, Mark P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 172
container_issue 3
container_start_page 159
container_title Neuromolecular medicine
container_volume 3
creator Gilman, Charles P
Chan, Sic L
Guo, Zhihong
Zhu, Xiaoxiang
Greig, Nigel
Mattson, Mark P
description A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders.
doi_str_mv 10.1385/NMM:3:3:159
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_883438701</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2425583861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-c1ee8c523b653dff955f3dc8b349e2dfbb693434d4d4fbcb7e1b25b5dc94e7083</originalsourceid><addsrcrecordid>eNpNUctOwzAQtBCI94k7srhCIY5j6nCreEstXOAc-bEBo9YOtgP0c_hTlrYSaA5e787MSjuEHLDilHEpzh4mkwuOYKJeI9tMcDFghazW_9VbZCelt6IoS8bYJtlipeRCMLZNvjvBqUu0i5DAZ-o8TXOvugSJfr5CBOoynYF1KmNn5nIwr8Hb6NSU2nlqe2-yC54qb5fC7Ay18AIeolpM0BG9u-AT0Bzo1cOIWjVTL3CyEIUvZ5H4AYsffBlckbFpUJj6aU57ZKNV0wT7q3eXPN9cP13eDcaPt_eXo_HAcFbmgWEA0oiS63PBbdvWQrTcGql5VUNpW63Pa17xyiJabfQQmC6FFtbUFQwLyXfJ0dK3i-G9h5Sbt9BHjysbKVEphwVD0vGSZGJIKULbdNHNVJw3rGh-02gwjYYjMA1kH64se403_OOuzs9_ALR2iUU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>883438701</pqid></control><display><type>article</type><title>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>Gilman, Charles P ; Chan, Sic L ; Guo, Zhihong ; Zhu, Xiaoxiang ; Greig, Nigel ; Mattson, Mark P</creator><creatorcontrib>Gilman, Charles P ; Chan, Sic L ; Guo, Zhihong ; Zhu, Xiaoxiang ; Greig, Nigel ; Mattson, Mark P</creatorcontrib><description>A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders.</description><identifier>ISSN: 1535-1084</identifier><identifier>EISSN: 1535-1084</identifier><identifier>EISSN: 1559-1174</identifier><identifier>DOI: 10.1385/NMM:3:3:159</identifier><identifier>PMID: 12835511</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Animals ; Apoptosis ; Benzothiazoles ; Brain - drug effects ; Brain - metabolism ; Brain - physiopathology ; Cell death ; Cells, Cultured ; Cellular biology ; Deoxyribonucleic acid ; DNA ; DNA damage ; DNA Damage - drug effects ; DNA Damage - genetics ; Etoposide ; Etoposide - pharmacology ; Excitotoxicity ; Hippocampus ; Membrane potential ; Membrane Potentials - drug effects ; Membrane Potentials - genetics ; Mice ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - genetics ; Mitochondria - metabolism ; Nervous system ; Neurodegeneration ; Neurodegenerative diseases ; Neurodegenerative Diseases - genetics ; Neurodegenerative Diseases - metabolism ; Neurodegenerative Diseases - physiopathology ; Neurology ; Neurons ; Neuroprotective Agents - pharmacology ; Neurotoxins - pharmacology ; Nucleic Acid Synthesis Inhibitors - pharmacology ; Oxidative Stress - drug effects ; Oxidative Stress - genetics ; p53 Protein ; Phosphorylation ; Presynaptic Terminals - drug effects ; Presynaptic Terminals - metabolism ; Presynaptic Terminals - pathology ; Proteins ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Synapsin I ; Synapsins - metabolism ; Synaptosomes ; Thiazoles - pharmacology ; Toluene - analogs &amp; derivatives ; Toluene - pharmacology ; Tumor Suppressor Protein p53 - genetics ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>Neuromolecular medicine, 2003-01, Vol.3 (3), p.159-172</ispartof><rights>Humana Press Inc 2003.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-c1ee8c523b653dff955f3dc8b349e2dfbb693434d4d4fbcb7e1b25b5dc94e7083</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12835511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilman, Charles P</creatorcontrib><creatorcontrib>Chan, Sic L</creatorcontrib><creatorcontrib>Guo, Zhihong</creatorcontrib><creatorcontrib>Zhu, Xiaoxiang</creatorcontrib><creatorcontrib>Greig, Nigel</creatorcontrib><creatorcontrib>Mattson, Mark P</creatorcontrib><title>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</title><title>Neuromolecular medicine</title><addtitle>Neuromolecular Med</addtitle><description>A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Benzothiazoles</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Brain - physiopathology</subject><subject>Cell death</subject><subject>Cells, Cultured</subject><subject>Cellular biology</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA damage</subject><subject>DNA Damage - drug effects</subject><subject>DNA Damage - genetics</subject><subject>Etoposide</subject><subject>Etoposide - pharmacology</subject><subject>Excitotoxicity</subject><subject>Hippocampus</subject><subject>Membrane potential</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - genetics</subject><subject>Mice</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - genetics</subject><subject>Mitochondria - metabolism</subject><subject>Nervous system</subject><subject>Neurodegeneration</subject><subject>Neurodegenerative diseases</subject><subject>Neurodegenerative Diseases - genetics</subject><subject>Neurodegenerative Diseases - metabolism</subject><subject>Neurodegenerative Diseases - physiopathology</subject><subject>Neurology</subject><subject>Neurons</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Neurotoxins - pharmacology</subject><subject>Nucleic Acid Synthesis Inhibitors - pharmacology</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - genetics</subject><subject>p53 Protein</subject><subject>Phosphorylation</subject><subject>Presynaptic Terminals - drug effects</subject><subject>Presynaptic Terminals - metabolism</subject><subject>Presynaptic Terminals - pathology</subject><subject>Proteins</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Synapsin I</subject><subject>Synapsins - metabolism</subject><subject>Synaptosomes</subject><subject>Thiazoles - pharmacology</subject><subject>Toluene - analogs &amp; derivatives</subject><subject>Toluene - pharmacology</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>1535-1084</issn><issn>1535-1084</issn><issn>1559-1174</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpNUctOwzAQtBCI94k7srhCIY5j6nCreEstXOAc-bEBo9YOtgP0c_hTlrYSaA5e787MSjuEHLDilHEpzh4mkwuOYKJeI9tMcDFghazW_9VbZCelt6IoS8bYJtlipeRCMLZNvjvBqUu0i5DAZ-o8TXOvugSJfr5CBOoynYF1KmNn5nIwr8Hb6NSU2nlqe2-yC54qb5fC7Ay18AIeolpM0BG9u-AT0Bzo1cOIWjVTL3CyEIUvZ5H4AYsffBlckbFpUJj6aU57ZKNV0wT7q3eXPN9cP13eDcaPt_eXo_HAcFbmgWEA0oiS63PBbdvWQrTcGql5VUNpW63Pa17xyiJabfQQmC6FFtbUFQwLyXfJ0dK3i-G9h5Sbt9BHjysbKVEphwVD0vGSZGJIKULbdNHNVJw3rGh-02gwjYYjMA1kH64se403_OOuzs9_ALR2iUU</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Gilman, Charles P</creator><creator>Chan, Sic L</creator><creator>Guo, Zhihong</creator><creator>Zhu, Xiaoxiang</creator><creator>Greig, Nigel</creator><creator>Mattson, Mark P</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20030101</creationdate><title>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</title><author>Gilman, Charles P ; Chan, Sic L ; Guo, Zhihong ; Zhu, Xiaoxiang ; Greig, Nigel ; Mattson, Mark P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-c1ee8c523b653dff955f3dc8b349e2dfbb693434d4d4fbcb7e1b25b5dc94e7083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Benzothiazoles</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Brain - physiopathology</topic><topic>Cell death</topic><topic>Cells, Cultured</topic><topic>Cellular biology</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA damage</topic><topic>DNA Damage - drug effects</topic><topic>DNA Damage - genetics</topic><topic>Etoposide</topic><topic>Etoposide - pharmacology</topic><topic>Excitotoxicity</topic><topic>Hippocampus</topic><topic>Membrane potential</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - genetics</topic><topic>Mice</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - genetics</topic><topic>Mitochondria - metabolism</topic><topic>Nervous system</topic><topic>Neurodegeneration</topic><topic>Neurodegenerative diseases</topic><topic>Neurodegenerative Diseases - genetics</topic><topic>Neurodegenerative Diseases - metabolism</topic><topic>Neurodegenerative Diseases - physiopathology</topic><topic>Neurology</topic><topic>Neurons</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Neurotoxins - pharmacology</topic><topic>Nucleic Acid Synthesis Inhibitors - pharmacology</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - genetics</topic><topic>p53 Protein</topic><topic>Phosphorylation</topic><topic>Presynaptic Terminals - drug effects</topic><topic>Presynaptic Terminals - metabolism</topic><topic>Presynaptic Terminals - pathology</topic><topic>Proteins</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Synapsin I</topic><topic>Synapsins - metabolism</topic><topic>Synaptosomes</topic><topic>Thiazoles - pharmacology</topic><topic>Toluene - analogs &amp; derivatives</topic><topic>Toluene - pharmacology</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilman, Charles P</creatorcontrib><creatorcontrib>Chan, Sic L</creatorcontrib><creatorcontrib>Guo, Zhihong</creatorcontrib><creatorcontrib>Zhu, Xiaoxiang</creatorcontrib><creatorcontrib>Greig, Nigel</creatorcontrib><creatorcontrib>Mattson, Mark P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Neuromolecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilman, Charles P</au><au>Chan, Sic L</au><au>Guo, Zhihong</au><au>Zhu, Xiaoxiang</au><au>Greig, Nigel</au><au>Mattson, Mark P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</atitle><jtitle>Neuromolecular medicine</jtitle><addtitle>Neuromolecular Med</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>3</volume><issue>3</issue><spage>159</spage><epage>172</epage><pages>159-172</pages><issn>1535-1084</issn><eissn>1535-1084</eissn><eissn>1559-1174</eissn><abstract>A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>12835511</pmid><doi>10.1385/NMM:3:3:159</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1535-1084
ispartof Neuromolecular medicine, 2003-01, Vol.3 (3), p.159-172
issn 1535-1084
1535-1084
1559-1174
language eng
recordid cdi_proquest_journals_883438701
source MEDLINE; SpringerLink (Online service)
subjects Animals
Apoptosis
Benzothiazoles
Brain - drug effects
Brain - metabolism
Brain - physiopathology
Cell death
Cells, Cultured
Cellular biology
Deoxyribonucleic acid
DNA
DNA damage
DNA Damage - drug effects
DNA Damage - genetics
Etoposide
Etoposide - pharmacology
Excitotoxicity
Hippocampus
Membrane potential
Membrane Potentials - drug effects
Membrane Potentials - genetics
Mice
Mitochondria
Mitochondria - drug effects
Mitochondria - genetics
Mitochondria - metabolism
Nervous system
Neurodegeneration
Neurodegenerative diseases
Neurodegenerative Diseases - genetics
Neurodegenerative Diseases - metabolism
Neurodegenerative Diseases - physiopathology
Neurology
Neurons
Neuroprotective Agents - pharmacology
Neurotoxins - pharmacology
Nucleic Acid Synthesis Inhibitors - pharmacology
Oxidative Stress - drug effects
Oxidative Stress - genetics
p53 Protein
Phosphorylation
Presynaptic Terminals - drug effects
Presynaptic Terminals - metabolism
Presynaptic Terminals - pathology
Proteins
Reactive oxygen species
Reactive Oxygen Species - metabolism
Synapsin I
Synapsins - metabolism
Synaptosomes
Thiazoles - pharmacology
Toluene - analogs & derivatives
Toluene - pharmacology
Tumor Suppressor Protein p53 - genetics
Tumor Suppressor Protein p53 - metabolism
title p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T13%3A44%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=p53%20is%20present%20in%20synapses%20where%20it%20mediates%20mitochondrial%20dysfunction%20and%20synaptic%20degeneration%20in%20response%20to%20DNA%20damage,%20and%20oxidative%20and%20excitotoxic%20insults&rft.jtitle=Neuromolecular%20medicine&rft.au=Gilman,%20Charles%20P&rft.date=2003-01-01&rft.volume=3&rft.issue=3&rft.spage=159&rft.epage=172&rft.pages=159-172&rft.issn=1535-1084&rft.eissn=1535-1084&rft_id=info:doi/10.1385/NMM:3:3:159&rft_dat=%3Cproquest_cross%3E2425583861%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=883438701&rft_id=info:pmid/12835511&rfr_iscdi=true